en · de · es · fr · pt
aod-9604-notes.peptides6155.com › News › Regulation And Detection Context — Questions and Answers

Regulation And Detection Context — Questions and Answers

By Editorial Desk · published 2026-07-03 · last reviewed 2026-08-01 · News

lipogenesis is one of those subjects where the details matter more than the headlines. This page pulls together the background, the mechanisms, and the practical points readers ask about most.

Last reviewed on 2026-08-01. Where a claim depends on a specific study, the study is described rather than over-claimed.

Regulation and Detection Context

Regulatory interest in AOD-9604 increased after high-profile anti-doping cases involving peptide products. In some cases, the substance was supplied under alternative names or in compounded preparations, complicating traceability. Sports tribunals and anti-doping panels have discussed whether the peptide was explicitly banned at the time of use, leading to clarifications by the World Anti-Doping Agency. For consumers and researchers, the legal status can vary by jurisdiction, and products marketed as research chemicals may lack independent quality verification.

AOD-9604 is listed as a prohibited substance in sport by the World Anti-Doping Agency. It falls under the peptide hormones, growth factors, related substances, and mimetics class on the prohibited list. Anti-doping organizations treat its presence in an athlete's sample as an adverse finding unless a therapeutic use exemption applies. The prohibition reflects concerns about performance enhancement in competitive settings and the difficulty of distinguishing exogenous peptide use from endogenous hormone fragments.

Detection of AOD-9604 in biological samples relies on analytical techniques capable of distinguishing a small synthetic peptide from related endogenous sequences. Liquid chromatography coupled with tandem mass spectrometry is commonly used for confirmatory analysis. Sample preparation may involve immunoaffinity enrichment or solid-phase extraction to concentrate the peptide. Because the molecule is small and may be present at low concentrations, assay sensitivity and specificity are ongoing analytical challenges. Laboratories also validate methods against reference materials when available.

Research and Regulatory Status

Regulatory treatment of AOD-9604 has varied. In sports anti-doping, the peptide became widely discussed during a 2013 investigation into an Australian professional sports club. Authorities at the time debated whether it fell under prohibitions on growth hormone and related substances. Later clarifications and updated lists have addressed the compound in different ways. Anyone seeking current status should consult the latest applicable rules, and commercial supply for human use is not authorized in major markets.

Research interest in AOD-9604 often focuses on whether it can influence lipid metabolism without the growth-promoting or glucose-related effects of full-length hGH. This question remains unresolved, and findings depend on model, dose, and measurement method. Some reviews treat the peptide as a historical obesity candidate rather than an active therapeutic. Others cite it in discussions of peptide fragments, metabolic signaling, and performance-enhancing substances. Clear conclusions are limited by the small number of rigorous, independent human studies.

Aod-9604 at a glance

PropertyValueNotes
Regulatory statusProhibited in sportListed by WADA under peptide hormones
WADA classS2Peptide hormones, growth factors, related substances, and mimetics
Approved therapeutic useNot establishedClinical research did not lead to broad marketing approval
Common detection methodLC-MS/MSLiquid chromatography-tandem mass spectrometry
Sample preparationExtraction and enrichmentImmunoaffinity or solid-phase extraction may be used

Measurement and Storage Practices

Quality control for AOD-9604 involves verifying identity, purity, and concentration. Suppliers may provide a certificate of analysis listing HPLC purity and mass spectrometry data. Independent verification is advised because peptide products can vary in quality. Researchers should check for counterions, residual solvents, and microbial contamination. Proper documentation supports reproducibility and safety in laboratory studies. When sourcing, institutions often require third-party testing and detailed chain-of-custody records. These steps help ensure that experimental results are attributable to the peptide rather than impurities.

Analytical characterization of AOD-9604 typically employs reversed-phase high-performance liquid chromatography (RP-HPLC) to assess purity and identity. Mass spectrometry provides confirmation of molecular mass, while amino acid analysis can verify composition. These methods are standard for peptide research chemicals. Because the peptide lacks a distinct chromophore, detection often relies on ultraviolet absorbance at 214 nm or mass spectrometric response. Laboratories may also use capillary electrophoresis for separation. For example, size-exclusion chromatography can detect aggregates.

Related pages on this site

Mechanism and Regulatory Status

Regulatory treatment of AOD-9604 is shaped by its classification as a peptide hormone. The World Anti-Doping Agency lists it as a prohibited substance, and many national anti-doping organizations adopt that list. It does not hold approval as a prescription medicine in the United States, the European Union, or other major markets. Products sold online are frequently labeled for research use only and may not undergo independent quality testing. Import and possession rules differ by country, so legal status depends on local law.

Proposed mechanisms for AOD-9604 focus on fat cells. Laboratory studies suggest the peptide can increase lipolysis, the breakdown of stored fat, and reduce lipogenesis, the formation of new fat. Unlike full human growth hormone, it does not appear to stimulate substantial IGF-1 production in the studies reported so far. Some evidence points to beta-adrenergic signaling, but the precise receptor targets and downstream pathways remain unresolved. The fragment is not thought to act through the classical growth hormone receptor.

Background from the literature

===== MeSH D08.811.520.232 – carbon-nitrogen lyases (EC 4.3) ===== MeSH D08.811.520.232.300 – amidine-lyases MeSH D08.811.520.232.300.200 – adenylosuccinate lyase MeSH D08.811.520.232.300.400 – argininosuccinate lyase MeSH D08.811.520.232.300.400.500 – delta-crystallins MeSH D08.811.520.232.400 – ammonia-lyases MeSH D08.811.520.232.400.200 – aspartate ammonia-lyase MeSH D08.811.520.232.400.350 – ethanolamine ammonia-lyase MeSH D08.811.520.232.400.500 – histidine ammonia-lyase MeSH D08.811.520.232.400.600 – l-serine dehydratase MeSH D08.811.520.232.400.700 – phenylalanine ammonia-lyase MeSH D08.811.520.232.400.850 – threonine dehydratase

Thus these two experiments are used to build so called spin systems, that is build a list of resonances of the chemical shift of the peptide proton, the alpha protons and all the protons from each residue's sidechain. Which chemical shifts corresponds to which nuclei in the spin system is determined by the conventional correlation spectroscopy connectivities and the fact that different types of protons have characteristic chemical shifts. To connect the different spinsystems in a sequential order, the nuclear Overhauser effect spectroscopy experiment has to be used. Because this experiment transfers magnetization through space, it will show crosspeaks for all protons that are close in space regardless of whether they are in the same spin system or not. The neighbouring residues are inherently close in space, so the assignments can be made by the peaks in the NOESY with other spin systems. One important problem using homonuclear nuclear magnetic resonance is overlap between peaks. This occurs when different protons have the same or very similar chemical shifts. This problem becomes greater as the protein becomes larger, so homonuclear nuclear magnetic resonance is usually restricted to small proteins or peptides.

=== Reliability === Shock resistance: LEDs, being solid-state components, are difficult to damage with external shock, unlike fluorescent and incandescent bulbs, which are fragile. Thermal runaway: Parallel strings of LEDs will not share current evenly due to the manufacturing tolerances in their forward voltage. Running two or more strings from a single current source may result in LED failure as the devices warm up. If forward voltage binning is not possible, a circuit is required to ensure even distribution of current between parallel strands. Slow failure: LEDs mainly fail by dimming over time, rather than the abrupt failure of incandescent bulbs. Lifetime: LEDs can have a relatively long useful life. One report estimates 35,000 to 50,000 hours of useful life for white LEDs, though time to complete failure may be shorter or longer. Fluorescent tubes typically are rated at about 10,000 to 25,000 hours, depending partly on the conditions of use, and incandescent light bulbs at 1,000 to 2,000 hours. Several DOE demonstrations have shown that reduced maintenance costs from this extended lifetime, rather than energy savings, is the primary factor in determining the payback period for an LED product. Cycling: LEDs are ideal for uses subject to frequent on-off cycling, unlike incandescent and fluorescent lamps that fail faster when cycled often, or high-intensity discharge lamps (HID lamps) that require a long time to warm up to full output and to cool down before they can be lighted again if they are being restarted.

== Inhibition == Although cartilage breakdown is important for the metabolic process and removing dead cells, unregulated degradation can cause illness. The regulatory mechanisms in place are inhibitory proteins known as tissue inhibitors of metalloproteinases. A large contributor to the inhibition is TIMP3 halting enzymes ADAMTS4 and ADAMTS5. In order for TIMP3 to conduct its functions it binds to negatively charged components of the extracellular matrix allowing it to remain localized where aggrecan degradation occurs. The inhibition has been shown to be more of a reactionary response instead of a precautionary action. It increases its expression when conditions such as osteoarthritis is present. Along with the natural inhibition of TIMP3 scientist are conducting research to create synthetic inhibitors. This is a work in progress as the main issue is the inhibitors are not specific enough and are blocking other enzymes.

Sources: en.wikipedia.org

Further detail

The Maronite Catholics and the Druze set the foundation for what is now Lebanon in the early 18th century, through a governing and social system known as the "Maronite-Druze dualism" in Mount Lebanon Mutasarrifate. Interaction between Christians (members of the Maronite, Eastern Orthodox, Melkite, and other churches) and the Druze resulted in the establishment and existence of mixed villages and towns in Mount Lebanon, Chouf, Wadi al-Taym, Jabal al-Druze, the Galilee region, Mount Carmel, and the Golan Heights. Druze doctrine teaches that Christianity is to be "esteemed and praised", as the Gospel writers are regarded as "carriers of wisdom". Additionally, the Druze catechism prophesies the dominance of Christianity over Islam in the Last Judgment. The Druze faith incorporates some elements of Christianity, along with adopting Christian elements and teachings found in the Epistles of Wisdom. Both religions revered and hold Jesus in high regard as a central figure and the awaited messiah, alongside other shared figures such as the Virgin Mary, John the Baptist, Saint George, Elijah, Luke the Evangelist, and Job. Moreover, important figures from the Old Testament such as Adam, Noah, Abraham, Moses, and Jethro are considered important prophets of God in the Druze faith, being among the seven prophets who appeared in different periods of history.

The Food and Drug Administration (FDA) is a federal agency of the United States Department of Health and Human Services (HHS). The FDA is responsible for protecting and promoting public health through the control and supervision of food safety, tobacco products, caffeine products, dietary supplements, prescription and over-the-counter pharmaceutical drugs (medications), vaccines, biopharmaceuticals, blood transfusions, medical devices, electromagnetic radiation emitting devices (ERED), cosmetics, animal foods & feed, and veterinary products. The FDA's primary focus is enforcing the Federal Food, Drug, and Cosmetic Act (FD&C). However, the agency also enforces other laws, notably Section 361 of the Public Health Service Act as well as associated regulations. Much of this regulatory-enforcement work is not directly related to food or drugs but involves other regulated products like lasers, cellular phones, and condoms. In addition, the FDA uses its authority to mitigate diseases in a variety of contexts, from household pets to human sperm for use in assisted reproduction. The FDA is led by the commissioner of food and drugs, who is appointed by the president with the advice and consent of the Senate. The commissioner reports to the secretary of health and human services. Marty Makary is the current commissioner. The FDA's headquarters is located in the White Oak area of Silver Spring, Maryland, occupying the former Naval Ordnance Laboratory. The agency has 223 field offices and 13 laboratories located across the 50 states, the United States Virgin Islands, and Puerto Rico.

When the upper plate was connected to the negative pole of the battery and the lower plate to the positive pole, the glowing patch moved downwards, and when the polarity was reversed, the patch moved upwards.

MrMed is an online pharmacy for super-specialty medicines based in India. It was founded by Devashish Singh and Saurab Jain and has its headquarters in Chennai. In 2022, the company received an award from the Government of Tamil Nadu for its contributions to healthcare.

== Liquids or solvents == In many cases, the presence of water can prevent a reaction from happening, or cause undesirable products to form. To prevent this, anhydrous solvents must be used when performing certain reactions. Examples of reactions requiring the use of anhydrous solvents are the Grignard reaction and the Wurtz reaction. Solvents have typically been dried using distillation or by reaction with reactive metals or metal hydrides. These methods can be dangerous and are a common cause of lab fires. More modern techniques include the use of molecular sieves or a column purification system. Molecular sieves are far more effective than most common methods for drying solvents and are safer and require no special equipment for handling. Column solvent purification devices (generally referred to as Grubb's columns) recently became available, reducing the hazards (water reactive substances, heat) from the classical dehydrating methods. Anhydrous solvents are commercially available from chemical suppliers, and are packaged in sealed containers to maintain dryness. Typically anhydrous solvents will contain approximately 10 ppm of water and will increase in wetness if they are not properly stored. Organic solutions can be dried using a range of drying agents. Typically following a workup the organic extract is dried using magnesium sulfate or a similar drying agent to remove most remaining water. Anhydrous acetic acid is known as glacial acetic acid.

Sources: en.wikipedia.org

Frequently asked questions

Is AOD-9604 banned in sport?

Yes, the World Anti-Doping Agency classifies AOD-9604 as a prohibited peptide hormone and related substance. Its use by athletes is banned under the relevant anti-doping code.

How is AOD-9604 detected?

Confirmatory detection typically uses liquid chromatography with mass spectrometry. Immunoassays may be used for screening, but mass spectrometry provides structural confirmation.

Does AOD-9604 have approved therapeutic uses?

No widely approved therapeutic indication exists for AOD-9604. It has been investigated in clinical studies, but regulatory approvals for general medical use are not established.

Has AOD-9604 been approved as a medicine?

No major medicines regulator appears to have approved AOD-9604 for human therapeutic use. It has been studied in clinical trials, but those programs did not result in a marketed drug.

Network